Search Ontology:
ChEBI
(3R,6R,9S,12R,15R)-12-[(2S)-butan-2-yl]-3-(1H-indol-3-ylmethyl)-15-(2-methylpropyl)-6,9-di(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclodocosane-2,5,8,11,14,17,20-heptone
- Term ID
- CHEBI:227159
- Synonyms
-
- (3R,6R,9S,12R,15R)-12-[(2S)-butan-2-yl]-3-(1H-indol-3-ylmethyl)-15-(2-methylpropyl)-6,9-di(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclodocosane-2,5,8,11,14,17,20-heptone
- Definition
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
Show first 5 Terms
Phenotype
Phenotype resulting from (3R,6R,9S,12R,15R)-12-[(2S)-butan-2-yl]-3-(1H-indol-3-ylmethyl)-15-(2-methylpropyl)-6,9-di(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclodocosane-2,5,8,11,14,17,20-heptone
Phenotype where environments contain (3R,6R,9S,12R,15R)-12-[(2S)-butan-2-yl]-3-(1H-indol-3-ylmethyl)-15-(2-methylpropyl)-6,9-di(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclodocosane-2,5,8,11,14,17,20-heptone
Phenotype modified by environments containing (3R,6R,9S,12R,15R)-12-[(2S)-butan-2-yl]-3-(1H-indol-3-ylmethyl)-15-(2-methylpropyl)-6,9-di(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclodocosane-2,5,8,11,14,17,20-heptone
Phenotype affecting (3R,6R,9S,12R,15R)-12-[(2S)-butan-2-yl]-3-(1H-indol-3-ylmethyl)-15-(2-methylpropyl)-6,9-di(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclodocosane-2,5,8,11,14,17,20-heptone
Human Disease Model